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Abstract 
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome 
(NS) in adults. It may be primary, usually mediated by IgG4 anti-phospholipase A2 autoanti-
bodies or secondary to various other conditions. Guillain- Barré syndrome (GBS) has been 
associated with MN, but a cause and effect relation has not been proven. We present a case 
of concurrent development of GBS and severe NS, with renal biopsy demonstrating MN. IgG4 
stain was negative, indicating that most likely, the MN was secondary and probably caused 
by the underlying GBS. 
Introduction 
Membranous nephropathy (MN) is one of the most common causes of nephrotic syn-
drome (NS) in adults [1, 2]. Most cases are considered idiopathic (iMN), where auto- 
antibodies react with one or more podocyte antigens (e.g., the M-type phospholipase A2 
receptor [3]) to form the subepithelial deposits characteristic of all types of MN. However, in 
about 25% of the cases a secondary cause can be found, including lupus, viral infections 
(most notably hepatitis B), cancer, and medications [4]. Sometimes, a specific relevant 
antigen can be detected in the subepithelial deposits. These include the hepatitis e antigen in 
cases related to hepatitis B [5], carcinoembryonic antigen in colon carcinoma [6], and 
cationic bovine serum albumin in certain pediatric cases [7]. The pathologic features of both 
iMN and secondary MN are otherwise similar, but subtle differences do exist. For example, in 
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lupus MN there may be mesangial proliferation by light microscopy, ‘full house’ positivity by 
immunofluorescence microscopy, and mesangial electron dense deposits by electron 
microscopy; features not usually found in iMN [8]. In iMN, IgG4 is the most prominent 
subclass detected [9], whereas in secondary cases another subclass is usually found. 
Guillain-Barré syndrome (GBS) is a heterogeneous group of disorders with similar 
clinical presentations. Typically, it is an acute, self-limited, paralyzing illness, which peaks in 
2 to 4 weeks and then subsides [10]. Most cases in the USA (about 85%) result from a 
reversible, immunologically mediated, peripheral nerve demyelination. This is termed acute 
inflammatory demyelinating polyradiculoneuropathy [11]. In other cases (about 15%), the 
immunologic attack is against axons, with sparing of myelin. If just motor neurons are 
involved, it is called acute motor axonal neuropathy (AMAN); if sensory fibers are affected as 
well, the term is acute motor and sensory axonal neuropathy (ASMAN). Various autoantibod-
ies have been identified in this syndrome as well [12]. 
Glomerulonephritis has been found in association with GBS [13–19]. Some patients had 
pathologic confirmation but only mild clinical manifestations [14]. More commonly, 
however, reported cases had NS, and the most common lesion was MN [15, 17–19]. It is 
unclear whether this results from autoantibodies against podocyte antigens as in iMN or 
rather against an extrinsic (to the podocyte) antigen as in secondary cases. We present a 
case of severe NS occurring simultaneously with severe GBS of the axonal variety. Renal 
biopsy revealed MN, although immunohistochemical stain for IgG4 was completely negative. 
This suggests that the MN was indeed secondary, perhaps to an antigen released by the 
primary nerve damage. We discuss this in detail in light of the current knowledge of the iMN 
pathophysiology. 
Case Presentation 
A 69-year-old man with a history of hypertension, hypothyroidism, dyslipidemia, ob-
structive sleep apnea, benign prostatic hypertrophy, and stroke was in his usual state of 
health until bilateral lower extremity edema developed rapidly over a 2-week period. He 
developed shortness of breath and was admitted to an outside hospital. On examination, 
blood pressure was 142/112, pulse 69, respirations 18, temperature 37°C, and oxygen 
saturation 96% on 2 liters oxygen by nasal cannula. There were 2+ lower extremity edema 
and mild right hand weakness, but no other focal neurologic findings. A chest radiograph 
revealed cardiomegaly; however, no infiltrates or evidence of interstitial edema. Complete 
blood count was normal, as were coagulation studies and electrolytes. Creatinine was 1.4 
mg/dl and albumin 2.4 g/dl, but liver function tests were otherwise normal. 24-h urine total 
protein excretion was 20,144 mg/day. Several days after admission, the patient began to 
complain about arm and leg numbness. Lumbar puncture showed a glucose level of 169 
mg/dl, a protein level of 35 mg/dl, WBC of 0/µl, and RBC of 1/µl. The weakness progressed 
over several days and GBS was diagnosed. He was transferred to our hospital for further 
evaluation. 
On transfer, the patient stated his right hand weakness began about 3 weeks prior to the 
lower extremity edema. He described slow worsening of this weakness and progressive right 
leg weakness. On neurological exam, he had no cranial nerve abnormalities, and his sensory 
exam was normal except for decreased pin-prick sensation on the left leg up to the knee. 
Motor exam showed 2/5 strength in his right deltoid and 4/5 in the left, biceps 4/5 
bilaterally, triceps 4/5 bilaterally, wrist flexors 4/5 bilaterally, interossei 3/5 on the right 
and 4/5 on the left, hip flexors 3/5 on the right and 4/5 on the left, knee extensors 3/5 on 
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the right and 4/5 on the left, and dorsiflexion 4/5 bilaterally. A Mini-Mental State Examina-
tion did not demonstrate any cognitive impairment. Reflex exam was 1+ to 2+ with the 
exception of 0 bilateral ankle reflex; there was no Babinski reflex. An electromyography 
showed a severe axonal and demyelinating motor and sensory polyneuropathy. The patient 
was treated with a 5-day course of intravenous immunoglobulin, which showed no 
significant improvement. Laboratory results were negative for neuromyelitis optica 
antibodies, rheumatoid factor, complements, antinuclear antibodies, and Lyme titers. The 
renal biopsy showed MN, with diffuse thickening of glomerular basement membranes with 
spikes on the epithelial side and interstitial fibrosis in about 20% of the cortical surface area 
(fig. 1). Immunofluorescence microscopy showed 2 to 3+ granular IgG staining of glomerular 
capillary walls. IgG4 subclass stain was negative. IgG1, IgG2, and IgG3 subclass stains are not 
routinely done at our institution. Electron microscopy revealed subepithelial electron dense 
deposits uniformly distributed throughout the glomerular capillary walls (fig. 2). The patient 
received a second round of intravenous immunoglobulin, which had to be discontinued due 
to acute kidney injury, however. He became intermittently hypotensive and required 
norepinephrine for blood pressure support. A positive urine culture for Klebsiella was 
treated with bactrim for 5 days. Weakness progressed and he required intubation. The 
patient developed facial diplegia, ophthalmoplegia as well as decreased corneal reflexes, and 
was found to be quadriplegic. The next day, he became hypotensive and bradycardic and 
proceeded to polymorphic ventricular tachycardia, which responded to cardioversion. Due 
to persistent refractory shock, care was withdrawn and the patient subsequently expired. 
Discussion 
Our case presented with concurrent NS and an axonal variety of GBS, which proved fatal. 
The underlying renal histology was clearly MN. The complete absence of IgG4 staining 
suggests that this was not the chance occurrence of iMN, but rather a true secondary case. 
Renal disease in the setting of GBS is not common clinically, but it has been known for 
many years, first described in a clinicopathologic report from 1918 [13]. In the ensuing 
years, renal involvement was only occasionally noted. In 1973, Rodríguez-Iturbe et al. [14] 
described a consecutive series of 9 patients of whom 8 had biopsy evidence of glomerulone-
phritis. However, the clinical manifestations were minor, with either transient hypertension, 
hematuria or both. That same year, 2 case reports described NS in association with GBS [15, 
16]. Both showed underlying MN, and 1 characterized the subclass as IgG4. Various case 
reports of NS have appeared since then, and the association has extended to the subacute 
[20] and chronic inflammatory polyneuropathies [21–23] as well as GBS. Most commonly, 
the glomerular lesion is MN, although minimal change disease has also been reported 
[24, 25]. 
MN is the most common cause of NS in adults, although it may present with subnephrot-
ic proteinuria. Most cases are considered idiopathic, but about 25% have defined secondary 
causes. These include viruses (hepatitis B or rarely C), cancers, medications (mercury, gold, 
penicillamine, NSAIDs, etc.), autoimmune diseases (lupus, sarcoid, etc.), and others. Included 
in the latter is GBS. The issue is whether this is merely a chance association without 
pathogenic relationship or not. 
The absence of IgG4 in our case suggests they are related. iMN is usually characterized 
by a strong IgG4 reaction detectable by immunofluorescence [9, 26]. It has recently been 
determined that these IgG4 antibodies may react with antigens normally expressed on the 
podocyte cell membrane (M-type phospholipase A2 receptor) [3], or only abnormally so 
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(aldose reductase [27], superoxide dismutase [27], α-enolase [28]). The antigen-antibody 
complexes are then shed to form the characteristic subepithelial deposits seen on electron 
microscopy. In general, an IgG4 response occurs after many months of chronic antigenic 
exposure, such as may occur with bee keepers or parasitic infestations [29]. It remains 
unknown what initiates this response in iMN. 
In secondary MN, other antigens extrinsic to the glomerulus appear to be involved. 
These include hepatitis B viral antigens, tumor-related antigens, DNA, and cationic bovine 
serum albumin. The antigen may first plant in the glomerulus, with in situ formation of the 
immune complex, or, less likely, circulating immune complexes may deposit [30]. In any 
case, the immunoglobulins are usually not of the IgG4 subclass. There are several potential 
mechanisms by which GBS and secondary MN may be pathogenically related. 
Various autoantibodies have been detected in different forms of GBS. Antibodies against 
the ganglioside GQ1b are found in most patients with the Miller Fisher variant of acute 
inflammatory demyelinating polyradiculoneuropathy [31], and antibodies against GM1, 
GD1a, and GD1b may be found with axonal variants [11]. These antibodies are thought to 
arise from molecular mimicry from a preceding infectious agent such as Campylobacter 
jejuni. It is possible that in occasional patients, these antibodies react, also through molecular 
mimicry, with one or more antigens expressed on podocyte cell membranes. Alternatively, 
damage to peripheral nerves may result in the release of an antigen(s), which deposits in the 
subepithelial space. The respective antibodies then bind, resulting in in situ immune 
complex formation. Finally, preformed circulating immune complexes involving one or more 
neural antigens may deposit in the subepithelial space [30]. Irrespective of the actual 
mechanism, MN is secondary to the primary nerve disease. The rather acute nature of the 
apparent exposure would be consistent with a non-IgG4 response [29]. In the case of a true 
infectious cause of GBS, the infectious agent itself could similarly deposit as the inciting 
antigen, form in situ immune complexes, and cause MN as well. 
In MN associated with GBS, the renal lesion usually appears to be self-limiting, resolving 
temporally along with improvement of the neuropathy. These cases would obviously not 
require immunosuppressive therapy for the renal lesion. Unfortunately, in cases associated 
with the chronic and/or relapsing neuropathies, the renal disease appears to persist as well. 
The optimal treatment for these cases from the renal standpoint remains unknown. 
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Fig. 1. Photomicrograph of a representative glomerulus from the renal biopsy. The glomerular basement 
membranes are thickened prominently and uniformly without evidence of cellular proliferation. 
Magnification, ×40. 
 
 
 
Fig. 2. Electron micrograph of a representative glomerulus from the renal biopsy. Subepithelial and 
intramembranous deposits are uniformly present throughout the glomerular basement membranes. 
Magnification, ×2,700. 
 
